The SARS-CoV-2 spike reversibly samples an open-trimer conformation exposing novel epitopes
- PMID: 35236990
- PMCID: PMC9007726
- DOI: 10.1038/s41594-022-00735-5
The SARS-CoV-2 spike reversibly samples an open-trimer conformation exposing novel epitopes
Abstract
Current COVID-19 vaccines and many clinical diagnostics are based on the structure and function of the SARS-CoV-2 spike ectodomain. Using hydrogen-deuterium exchange monitored by mass spectrometry, we have uncovered that, in addition to the prefusion structure determined by cryo-electron microscopy, this protein adopts an alternative conformation that interconverts slowly with the canonical prefusion structure. This new conformation-an open trimer-contains easily accessible receptor-binding domains. It exposes the conserved trimer interface buried in the prefusion conformation, thus exposing potential epitopes for pan-coronavirus antibody and ligand recognition. The population of this state and kinetics of interconversion are modulated by temperature, receptor binding, antibody binding, and sequence variants observed in the natural population. Knowledge of the structure and populations of this conformation will help improve existing diagnostics, therapeutics, and vaccines.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.
Conflict of interest statement
Competing Interests:
S.M.C., S.R.S. and S.M. are inventors on U.S. patent application no. 63/220,388, (“Methods related to an alternative conformation of the SARS-CoV-2 Spike Protein”). A.W.N., C.-L.H., J.S.M. and J.A.M. are inventors on U.S. patent application no. 63/135,913 (“Cross-reactive antibodies recognizing the coronavirus spike S2 domain”). J.S.M. is an inventor on U.S. patent application no. 62/412,703 (“Prefusion Coronavirus Spike Proteins and Their Use”). C.-L.H., J.A.M., and J.S.M. are inventors on U.S. patent application no. 63/032,502 (“Engineered Coronavirus Spike (S) Protein and Methods of Use Thereof”).
Figures
Similar articles
-
SARS-CoV-2 Spike Protein Stabilized in the Closed State Induces Potent Neutralizing Responses.J Virol. 2021 Jul 12;95(15):e0020321. doi: 10.1128/JVI.00203-21. Epub 2021 Jul 12. J Virol. 2021. PMID: 33963055 Free PMC article.
-
A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccination.Cell Rep. 2022 Aug 23;40(8):111276. doi: 10.1016/j.celrep.2022.111276. Epub 2022 Aug 11. Cell Rep. 2022. PMID: 35981534 Free PMC article.
-
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike.Cell Host Microbe. 2020 Sep 9;28(3):445-454.e6. doi: 10.1016/j.chom.2020.06.010. Epub 2020 Jun 19. Cell Host Microbe. 2020. PMID: 32585135 Free PMC article.
-
Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies.Biomed Pharmacother. 2020 Oct;130:110559. doi: 10.1016/j.biopha.2020.110559. Epub 2020 Aug 1. Biomed Pharmacother. 2020. PMID: 32768882 Free PMC article. Review.
-
Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting.Int J Mol Sci. 2022 Apr 14;23(8):4341. doi: 10.3390/ijms23084341. Int J Mol Sci. 2022. PMID: 35457159 Free PMC article. Review.
Cited by
-
Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2.Sci Rep. 2024 Jan 23;14(1):2038. doi: 10.1038/s41598-024-52499-1. Sci Rep. 2024. PMID: 38263191 Free PMC article.
-
Probing Mechanisms of Binding and Allostery in the SARS-CoV-2 Spike Omicron Variant Complexes with the Host Receptor: Revealing Functional Roles of the Binding Hotspots in Mediating Epistatic Effects and Communication with Allosteric Pockets.Int J Mol Sci. 2022 Sep 29;23(19):11542. doi: 10.3390/ijms231911542. Int J Mol Sci. 2022. PMID: 36232845 Free PMC article.
-
Broad strategies for neutralizing SARS-CoV-2 and other human coronaviruses with monoclonal antibodies.Sci China Life Sci. 2023 Apr;66(4):658-678. doi: 10.1007/s11427-022-2215-6. Epub 2022 Nov 24. Sci China Life Sci. 2023. PMID: 36443513 Free PMC article. Review.
-
Open-source milligram-scale, four channel, automated protein purification system.PLoS One. 2024 Feb 23;19(2):e0297879. doi: 10.1371/journal.pone.0297879. eCollection 2024. PLoS One. 2024. PMID: 38394072 Free PMC article.
-
Conformational stability of SARS-CoV-2 glycoprotein spike variants.iScience. 2023 Jan 20;26(1):105696. doi: 10.1016/j.isci.2022.105696. Epub 2022 Nov 30. iScience. 2023. PMID: 36465857 Free PMC article.
References
-
- Baum A, Fulton BO, Wloga E, Copin R, Pascal KE, Russo V, Giordano S, Lanza K, Negron N, Ni M, Wei Y, Atwal GS, Murphy AJ, Stahl N, Yancopoulos GD, Kyratsous CA, Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science. 369, 1014–1018 (2020). - PMC - PubMed
-
- Hansen J, Baum A, Pascal KE, Russo V, Giordano S, Wloga E, Fulton BO, Yan Y, Koon K, Patel K, Chung KM, Hermann A, Ullman E, Cruz J, Rafique A, Huang T, Fairhurst J, Libertiny C, Malbec M, Lee W-Y, Welsh R, Farr G, Pennington S, Deshpande D, Cheng J, Watty A, Bouffard P, Babb R, Levenkova N, Chen C, Zhang B, Romero Hernandez A, Saotome K, Zhou Y, Franklin M, Sivapalasingam S, Lye DC, Weston S, Logue J, Haupt R, Frieman M, Chen G, Olson W, Murphy AJ, Stahl N, Yancopoulos GD, Kyratsous CA, Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science. 369, 1010–1014 (2020). - PMC - PubMed
-
- Shi R, Shan C, Duan X, Chen Z, Liu P, Song J, Song T, Bi X, Han C, Wu L, Gao G, Hu X, Zhang Y, Tong Z, Huang W, Liu WJ, Wu G, Zhang B, Wang L, Qi J, Feng H, Wang F-S, Wang Q, Gao GF, Yuan Z, Yan J, A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature. 584, 120–124 (2020). - PubMed
Methods References:
-
- Byrum JR, Waltari E, Janson O, Guo S-M, Folkesson J, Chhun BB, Vinden J, Ivanov IE, Forst ML, Li H, Larson AG, Wu W, Tato CM, McCutcheon KM, Peluso MJ, Henrich TJ, Deeks SG, Prakash M, Greenhouse B, Pak JE, Mehta SB, multiSero: open multiplex-ELISA platform for analyzing antibody responses to SARS-CoV-2 infection. medRxiv (2021), doi:10.1101/2021.05.07.21249238. - DOI - PMC - PubMed
-
- Glasgow A, Glasgow J, Limonta D, Solomon P, Lui I, Zhang Y, Nix MA, Rettko NJ, Zha S, Yamin R, Kao K, Rosenberg OS, Ravetch JV, Wiita AP, Leung KK, Lim SA, Zhou XX, Hobman TC, Kortemme T, Wells JA, Engineered ACE2 receptor traps potently neutralize SARS-CoV-2. Proc. Natl. Acad. Sci. U. S. A (2020), doi:10.1073/pnas.2016093117. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
